United Therapeutics | UTHR - Ebit

Precio De Mercado
567.16
Cambio Diario
-5.69 -0.99%
Mensual
4.72%
Anual
94.65%
Q2 Expectativa
555.02




Ebit Cambio Fecha
Amarin USD -2.26M 564K 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Bayer EUR 1.11B 1.51B 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
J&J USD 6.62B 1.51B 2026-03
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Moderna USD -857M 597M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12